法夫酵母产虾青素的补料发酵

以法夫酵母 (Phaffiarhodozyma)WSS FF6为产生菌进行产虾青素的补料发酵 ,在通气量为 2 5 0L/h、pH =6.0± 0 .5的条件下 ,先流加高糖浓度的培养基 ,后添加 0 .1%乙醇 ,进行分批补料发酵 ,经 130h发酵后 ,生物量与类胡萝卜素产量分别为 2 7.4mg/mL、2 6.12 μg/mL ,生长得率、产物得率及酵母色素质量分数分别为 0 .4 6、0 .4 4和 0 .95     

放射型根瘤菌WSH2601生产辅酶Q10的摇瓶发酵条件

以放射型根瘤菌 (Rhizobusradiobacterium ,WSH2 6 0 1)作为辅酶Q10 的生产菌株 ,研究了氮源、碳源、接种量、溶氧、初始 pH、发酵温度及添加物等因素对细胞生长与产物辅酶Q10 合成的影响 .结果表明 :玉米浆和酵母膏是较好的氮源 ,葡萄糖与蔗糖是辅酶Q10 发酵的较好的碳源 ,接种量对辅酶Q10 发酵的影响不大 ,为 4 % .适宜的初始 pH值为 7,番茄汁能较好地促进细胞的生长 ;添加玉米浆、L 甲硫氨酸、番茄汁和异戊醇有利于产辅酶Q10 ;溶氧对细胞生长与产物辅酶Q10 合成的影响较显著 .通过正交试验初步确定了发酵条件 :碳源为 1.5 g/dL葡萄糖和 2 .5 g/dL蔗糖混合物 ,酵母膏 0 .8g/dL ,初始pH 7,每 5 0 0mL装液量为 5 0mL .最后经综合优化条件 ,在摇瓶发酵条件下 :菌体生长量 (以干重计 )为 13.8g/L ,发酵液中辅酶Q10 产量达到 2 2 .7mg/L ,比优化前分别提高 34%和 5 3% .     

L-乳酸高产突变株--米根霉NAF-032

运用正交试验理论,对L-乳酸高产突变株NAF-032的优化摇瓶发酵条件作了初步研究,确定了优化的发酵培养基和发酵条件.优化发酵培养基为(g/L)葡萄糖140,氯化铵1,KH2PO40.3,MgSO4*7H2O0.25,ZnSO4*7H2O0.08;优化培养条件为34℃,摇床转速200r/min,装液量50mL(250mL容积三角瓶),一次性添加CaCO380g/L调节pH值.米根霉NAF-032的摇瓶发酵L-乳酸积累量可达94.28g/L.     

圆弧青霉产碱性脂肪酶的中试发酵

圆弧青霉PG3 7是碱性脂肪酶的高产菌 ,在摇瓶和 2 5L发酵罐小试的基础上进行 3M3发酵罐中试 .适合的发酵条件为 :发酵培养基 (% )　豆饼粉 3 .0 ,玉米浆 3 .0 ,磷酸氢二钾 1 .0 ,硫酸镁0 .1 ,大豆磷脂 0 .5,柠檬酸钠 0 .0 5,花生油 0 .2 ;发酵起始 pH值为 8.0 ,发酵温度 2 9± 1℃ ,接种量8%～ 1 0 % ,通风量 0 .8L/ (L·min) ,搅拌转速 2 4 0r/min ,发酵周期 72h ,期间于 3 0、4 2、54h分别各流加 0 .4 %花生油 .在上述条件下 ,圆弧青霉PG3 7发酵酶活达 2 0 0 0 μmol/ (min·mL)     

圆弧青霉PG37碱性脂肪酶的发酵工艺条件

研究了圆弧青霉PG3 7碱性脂肪酶的发酵工艺条件 ,优化了PG3 7的摇瓶最适产酶条件 .其中 ,发酵培养基的组成为 (g/dL) :豆饼粉 3 .0 ,玉米浆 3 .0 ,磷酸氢二钾 1 .0 ,硫酸镁 0 .1 ,大豆磷脂0 .5,柠檬酸钠 0 .0 5,花生油 0 .2 ;发酵培养基起始 pH 7.5,发酵温度 (2 9± 1 )℃ ,摇床转速 2 50r/min ,发酵周期 96h ,发酵期间于 3 6,54,72h分别流加 0 .4 g/dL花生油 .在此条件下 ,PG3 7的脂肪酶产率为 2 0 60 μmol/ (min·mL) .PG3 7在 2 5L的实验室小罐中的产酶水平为 1 90 0 μmol/ (min·mL) .     

营养因子对鸡腿蘑分泌胞外多糖的影响

结合工业发酵的特点 ,研究了营养因子对鸡腿蘑 (毛头鬼伞 )胞外多糖产量的影响 ,筛选到适合其胞外多糖分泌的优化培养基配方 :葡萄糖 2 .0 % ,玉米粉 (6 0目 ) 1.0 % ,麸皮粉 (6 0目 )0 .3% ,VB110mg/L ,KH2 PO4 0 .1% ,MgSO4 ·7H2 O 0 .1% ,在此基础上进行摇瓶发酵曲线的测定 ,确定生产胞外多糖的适宜发酵周期为 4d ,发酵液中产量最高可达 96 .3mg/dL .     

重组大肠杆菌生产谷胱甘肽合成酶系的摇瓶发酵条件

研究了重组大肠杆菌E.coli Ⅱ-1 摇瓶发酵生产谷胱甘肽合成酶系的工艺条件，确定了E.coli Ⅱ-1 的最适产酶条件.最佳发酵培养基组成（g/L）为葡萄糖10, 蛋白胨5, 酵母膏2.5, K     

黄伞菌丝深层发酵的培养条件

采用摇瓶培养法对黄伞菌丝深层发酵培养条件进行了研究.通过正交试验初步确定黄伞菌丝深层发酵适宜的培养基组成为:葡萄糖3g/dL,牛肉膏1.5g/dL,K2HPO40.5g/dL,MgSO40.1g/dL.该菌株最适培养条件为:培养温度25℃,起始pH值5.0,接种体积分数15%,发酵周期10d.在优化的试验条件下,进行摇瓶发酵,菌丝干重达11.16g/L.     

粗状假丝酵母(Candida valida T2)生产脂肪酶的发酵条件

对粗状假丝酵母产生脂肪酶的培养条件进行了研究。结果表明,该菌株产脂肪酶的适宜培养基组成为:桐油15mL/L,黄豆粉30g/L,糊精10g/L,硝酸铵10g/L,MgSO4·7H2O1g/L,K2HPO42g/L,Tween800.5g/L;最佳培养为温度30℃、发酵液起始pH6,摇瓶发酵脂肪酶活力达到1467U/mL。     

无锡轻工大学学报2002年(第21卷)总目次

第 1期红酵母类胡萝卜素发酵助剂的筛选及应用王岁楼 ,刘凤珠 ,高建奇 (1 )……………………………………法夫酵母产虾青素的补料发酵徐学明 ,金征宇 ,刘当慧 (5)…………………………………………………硝酸盐在除磷脱氮中的作用邹华 ,阮文权 ,陈坚 (1 0 )………………………………………………………微波对甲壳素脱乙酰反应的影响张立彦 ,曾庆孝 ,林王旬等 (1 5)……………………………………………有机相酶促合成Ｎ 月桂酰 β 氨基丙腈 夏咏梅 ,许志国 ,胡学铮等 (2 0 )……………………………………强碱弱酸两性树脂的合成、结构性能及…     

Vasopressor hormone response following mesenteric traction during major abdominal surgery

Background : We investigated the vasopressor hormone response following mesenteric traction (MT) with hypotension due to prostacyclin (PGI₂) release in patients undergoing abdominal surgery with a combined general and epidural anesthesia. Methods : In a prospective, randomized, placebo-controlled study we administered 400 mg ibuprofen (i.v.) in 42 patients scheduled for abdominal surgery. General anesthesia was combined with epidural anesthesia (T4-L1). Before as well as 5, 15, 30, 45, and 90 min after MT we recorded plasma osmolality, hemodynamics and measured 6-keto-PGFlα (stabile metabolite of PGI₂), TXB₂ (stabile metabolite of thromboxane A₂) active renin, and arginine vasopressin (AVP) plasma concentrations by radioimmunoassay. Catecholamine levels were assessed by high-pressure liquid chromatography (HPLC) with electrochemical detection. Results : Following MT, arterial hypotension occurred along with a substantial PGI₂ release. This was completely abolished by ibuprofen administration. Although plasma levels of 6-keto-PGF_1α (1133 (708) vs. 60 (3) ng/L, median (median absolute deviation), P=0.0001, placebo vs. ibuprofen) remained significantly elevated, blood pressure was restored within 30 min after MT in the placebo group. At the same point in time plasma concentrations of TXB² (164 (87) vs. 58 (1) ng/L, P=0.0001), epinephrine (46 (33) vs. 14 (6) ng/L, P=0.001), AVP (41 ± (18) vs. 12 (7) ng/L, P=0.0004), and active renin (27 (12) vs. 12 (4) ng/L, P = 0.001) were significantly higher in placebo-treated patients. Conclusion : Under combined general and epidural anesthesia arterial hypotension following MT due to endogenous PGI₂ release is associated with enhanced release of AVP, active renin, epinephrine and thromboxane A₂, presumably contributing to hemodynamic stability within 30 min after MT.     

A Teaspoon Pump for Pumping Blood with High Hydraulic Efficiency and Low Hemolysis Potential

Abstract: Virtually all blood pumps contain some kind of rubbing, sliding, closely moving machinery surfaces that are exposed to the blood being pumped. These valves, internal bearings, magnetic bearing position sensors, and shaft seals cause most of the problems with blood pumps. The original teaspoon pump design prevented the rubbing, sliding machinery surfaces from contacting the blood. However, the hydraulic efficiency was low because the blood was able to "slip around" the rotating impeller so that the blood itself never rotated fast enough to develop adequate pressure. An improved teaspoon blood pump has been designed and tested and has shown acceptable hydraulic performance and low hemolysis potential. The new pump uses a nonrotating "swinging" hose as the pump impeller. The fluid enters the pump through the center of the swinging hose; therefore, there can be no fluid slip between the revolving blood and the revolving impeller. The new pump uses an impeller that is comparable to a flexible garden hose. If the free end of the hose were swung around in a circle like half of a jump rope, the fluid inside the hose would rotate and develop pressure even though the hose impeller itself did not "rotate"; therefore, no rotating shaft seal or internal bearings are required.     

Microspheres Based Detoxification System: A New Method in Convective Blood Purification

Abstract: A variety of protein-bound or hydrophobic substances, accumulating as a result of pathologic conditions such as exogenous or endogenous intoxications, are removed poorly by conventional detoxification methods because of low accessibility (hemodialysis), insufficient adsorption capabilities (hemosorption), low efficiency (peritoneal dialysis), or economic limitations (high-volume plasmapheresis). Combining advantages of existing methods with microspheric technology, a module-based system was designed. Major operating parameters of the latter can be modified to allow for adjustment to individual clinical situations. An extracorporeal blood circuit including a plasmafilter is combined with a secondary high-velocity plasma circuit driven by a centrifugal pump. Different microspheric adsorbers can be combined in one circuit or applied in sequence. Thus, a prolonged treatment can be tailored using specially designed selective adsorber materials. Comparing this system with existing methods (high-flux hemodialysis, molecular adsorbent recycling system), results from our in vitro studies and animal experiments demonstrate the superior efficiency of substance removal.     

Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil

Background : Our objective was to determine whether administration of propranolol or verapamil modifies the hemodynamic adaptation to continuous positive-pressure ventilation (CPPV), in particular the regional distribution of cardiac output (CO).
Methods : General hemodynamics and regional blood flows assessed by microsphere technique (15 (μm) were recorded in 16 anesthetized pigs during spontaneous breathing (SB) and CPPV with 8 cm H₂O end-expiratory pressure (CPPV8) before and after intravenous administration of propranolol (0.3 mg · kg⁻¹ followed by 0.15 mg · kg⁻¹ · h⁻¹, n=8) or verapamil (0.1 mg · kg⁻¹ followed by 0.3 mg · kg⁻¹ · h⁻¹, n=8).
Results : CPPV8 depressed CO by 25% without shifts in its relative distribution with the exception of a noteworthy increase in adrenal perfusion. Propranolol increased arterial blood pressure, and due to a fall in heart rate, CO dropped by 25%. The kidneys and, to a lesser extent, the splanchic region and central nervous system received increased fractions of the remaining CO at the expense of skeletal muscle flow. Similar patterns were seen during SB and CPPV8 such that the combination of propranolol and CPPV8 depressed CO by 50%. The circulatory effects of verapamil were less evident but myocardial perfusion tended to increase.
Conclusions : The combination of propranolol or verapamil with CPPV does not result in any specific hemodynamic interaction in anesthetized pigs, except that the combined effect of propranolol and CPPV may severely reduce CO.     

Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts

Background : Inhibitory effects of volatile anaesthetics on platelet aggregation have been demonstrated in several studies. However, the influence of volatile anaesthetics on intracoronary platelet adhesion has not been elucidated so far.
Methods : Isolated hearts of guinea pigs were perfused with buffer in the absence or presence of volatile anaesthetics (0.5 and 1 MAC) at constant coronary flow rates of 5 ml/min for 25 min, then 1 ml/min for 30 min and again 5 ml/min for 10 min. Before, during and after low-flow perfusion, a bolus of human platelets was applied into the coronary system. To simulate thrombogenic conditions, 0.3 U/ml human thrombin was infused during low-flow perfusion and reperfusion. The number of platelets sequestered to the endothelium was calculated from the difference between coronary in- and output of platelets. The myocardial production of lactate and consumption of pyruvate and coronary perfusion pressure were also determined.
Results : At a flow rate of 5 ml/min only about 3% of the applied platelets did not emerge from the coronary system, in any group. In contrast, 13.1±1.2% (mean±SEM) of infused platelets became adherent in low-flow perfusion in the control group without anaesthetic. The adherence was reduced with each 1 MAC isoflurane (to 6.2±1.2%), sevoflurane (to 4.4±0.9%) or halothane (to 3.2±1.5%) (each P <0.05 vs. control). Volatile anaesthetic, 0.5 MAC, did not inhibit platelet adhesion to a statistically significant extent in any case. Perfusion pressure and metabolic parameters were not statistically different between the control and the hearts exposed to anaesthetics.
Conclusion : Volatile anaesthetics in a concentration of 1 MAC can reduce the adhesion of platelets in the coronary system under reduced flow conditions. This action does not arise from vasodilation or inhibition of ischaemic stress.     

Bariatric Surgery in Some "Central and East-European (former Eastern bloc)"Countries - Current Status and Prediction for the Next Millennium

Background: Obesity is increasing globallly, including in the formerly "Eastern Bloc" countries. Methods: A survey was made of obesity and bariatric surgery. Results: In the 8 East and Central European countries studied, with total population 300 million, roughly 43% of the population was overweight (BMI 25-30), 23% obese (BMI > 30), with about 15 million people morbidly obese (BMI > 40). From 0-10 morbidly obese individuals/100,000/year undergo bariatric surgery. Conclusion: Most countries were found to provide inadequate treatment for obesity.The majority of the morbidly obese are not treated effectively. However, health-care awareness of obesity and bariatric surgeons are slowly increasing.     

Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits

Background: It has been shown that the depressive effects of both propofol and midazolam on consciousness are synergistic with opioids, but the nature of their interactions on other physiological systems, e. g. respiration, has not been fully investigated. The present study examined the effect of propofol and midazolam alone and in combination with fentanyl on phrenic nerve activity (PNA) and whether such interactions are additive or synergistic. Methods: PNA was recorded in 27 anaesthetised and artificially ventilated rabbits. In three groups, propofol, fentanyl and midazolam were administered intravenously in incremental doses to construct dose-response curves for the depressant effects of each one on PNA. In another two groups, the effect of pretreatment with either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. on the effects of propofol and fentanyl respectively on PNA were studied. Results: Propofol and fentanyl caused a dose-dependent depression of PNA with complete abolition at the highest total doses of 16 mg · kg^?1 i. v. and 32 μg · kg^?1 i. v., respectively. In contrast, midazolam in incremental doses to a total of 0.8 mg · kg^?1 reduced mean PNA by 63%, but approximately 12% of PNA remained at a total dose as high as 6.4 mg · kg^?1. The mean ED₅₀s, calculated from dose-response curves, were 5.4 mg · kg^?1, 3.9 μg · kg^?1 and 0.4 mg · kg^?1 for propofol, fentanyl and midazolam, respectively. Initial doses of either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. acted synergistically with subsequent doses of either propofol or fentanyl to abolish PNA at total doses of 8 mg · kg^?1 and 8 μg · kg^?1, respectively. Conclusion: Fentanyl has a synergistic interaction with both propofol and midazolam on PNA and hence potentially on respiration.     

Influence of dopexamine hydrochloride on haemodynamics and regulators of circulation in patients undergoing major abdominal surgery

Background: Catecholaminergic support is often used to improve haemodynamics in patients undergoing major abdominal surgery. Dopexamine is a synthetic vasoactive catecholamine with beneficial microcirculatory properties. Methods: The influence of perioperative administration of dopexamine on cardiorespiratory data and important regulators of macro- and microcirculation were studied in 30 patients undergoing Whipple pancreaticduodenectomy. The patients received randomized and blinded either 2 μg · kg^?1 · min^?1 of dopexamine (n=15) or placebo (n=15, control group). The infusion was started after induction of anaesthesia and continued until the morning of the first postoperative day. Endothelin-1 (ET-1), vasopressin, atrial natriuretic peptide (ANP), and catecholamine plasma levels were measured from arterial blood samples. Measurements were carried out after induction of anaesthesia, 2 h after onset of surgery, at the end of surgery, 2 h after surgery, and on the morning of the first postoperative day. Results: Cardiac index (CI) increased significantly in the dopexamine group (from 2.61±0.41 to 4.57±0.78 1 · min^?1 · m^?2) and remained elevated until the morning of the first postoperative day. Oxygen delivery index (DO₂I) and oxygen consumption index (VO₂I) were also significantly increased in the dopexamine group (DO₂I: from 416±91 to 717±110 ml/m² · m²; VO₂I: from 98±25 to 157±22 ml/m² · m²), being significantly higher than in the control group. pHi remained stable only in the dopexamine patients, indicating adequate splanchnic perfusion. Vasopressive regulators of circulation increased significantly only in the untreated control patients (vasopressin: from 4.37±1.1 to 35.9±12.1 pg/ml; ET-1: from 2.88±0.91 to 6.91±1.20 pg/ml). Conclusion: Patients undergoing major abdominal surgery may profit from prophylactic perioperative administration of dopexamine hydrochloride in the form of improved haemodynamics and oxygenation as well as beneficial influence on important regulators of organ blood flow.     

Immunomodulation in Transplantation with Photopheresis

Abstract: Photopheresis is a technique in which peripheral blood mononuclear cells, in the presence of a photoacti-vatable compound, are exposed extracorporeally to ultraviolet A light and reinfused, inducing a host autoregula-tory immune response. Experimental work and ongoing clinical studies are helping to define the role of this novel, safe, and non-toxic immunomodulating technology in the field of transplantation.